2m 2m 2m 2m 2m 2m 2m
CANDEL THERAPEUT (CADL)
NASDAQ
$10.08+$0.07 (+0.66%)
Price as of Aug 03, 2026 7:40 AM EDT- $733.4MMarket Cap
- 59.14%1-Year Change
- BiotechnologyIndustry
CANDEL THERAPEUT (CADL)
$10.08+$0.07 (+0.66%)
CADL | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $10.01 | ||
Change | +$0.14 (+1.42%) | ||
Open | $9.95 | ||
High | $10.13 | ||
Low | $9.80 | ||
Previous Close | $9.87 | ||
Volume | 1,117,505 | ||
30-Day Average Volume | 1,328,144 | ||
1-Week Change | 4.71% | ||
1-Month Change | -2.82% | ||
1-Year Change | 59.14% | ||
3-Year Change | 826.85% | ||
5-Year Change | 31.88% | ||
Fundamentals | |||
Shares Outstanding | 73.3M | ||
Total Assets | $201.9M | ||
Market Cap | $733.4M | ||
Enterprise Value | $586.1M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$8.9M | ||
Free Cash Flow | -$18.7M | ||
EBIT | -$7.3M | ||
EBITDA | -$7.1M | ||
Net Working Capital | $190.7M | ||
EPS | -$0.14 | ||
Enterprise Value/EBITDA | -82 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 5 | ||
P/E | -72 | ||
PEG | -1 | ||
Price/Free Cash Flow | -39 | ||
Price/Operating Cash Flow | -41 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue